Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "BAP1-Mutant Clear Cell Renal Cell Carcinoma"
Page 1
CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
Zhou Q, Qi Y, Wang Z, Zeng H, Zhang H, Liu Z, Huang Q, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Xu L, Dai B, Guo J, Zhu Y, Zhang W, Xu J. Zhou Q, et al. J Immunother Cancer. 2020 Apr;8(1):e000228. doi: 10.1136/jitc-2019-000228. J Immunother Cancer. 2020. PMID: 32371459 Free PMC article.
BACKGROUND: Patients with BRCA1-associated protein 1 (BAP1)-mutant clear cell renal cell carcinoma (ccRCC) have worse prognosis. ...RESULTS: Expression of CCR5 and its ligands were elevated in BAP1-mutant patie …
BACKGROUND: Patients with BRCA1-associated protein 1 (BAP1)-mutant clear cell renal cell carcin …
Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.
Liu Z, Lin D, Zhou Y, Zhang L, Yang C, Guo B, Xia F, Li Y, Chen D, Wang C, Chen Z, Leng C, Xiao Z. Liu Z, et al. Sci Rep. 2022 Aug 2;12(1):13222. doi: 10.1038/s41598-022-16657-7. Sci Rep. 2022. PMID: 35918352 Free PMC article.
The emerging targeted therapies have revolutionized the treatment of advanced clear cell renal cell carcinoma (ccRCC) over the past 15 years. Nevertheless, lack of personalized treatment limits the development of effective clinical guidelines an …
The emerging targeted therapies have revolutionized the treatment of advanced clear cell renal cell carcinoma …
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma.
Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK. Panda A, et al. JCI Insight. 2018 Aug 23;3(16):e121522. doi: 10.1172/jci.insight.121522. eCollection 2018 Aug 23. JCI Insight. 2018. PMID: 30135306 Free PMC article.
Although a subset of clear cell renal cell carcinoma (ccRCC) patients respond to immune checkpoint blockade (ICB), predictors of response remain uncertain. ...Similar results were observed in ER+/HER2- breast, colon, and head and neck squ …
Although a subset of clear cell renal cell carcinoma (ccRCC) patients respond to immune checkpoint blocka …
Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer.
Wang XY, Wang Z, Huang JB, Ren XD, Ye D, Zhu WW, Qin LX. Wang XY, et al. Tumour Biol. 2017 Jun;39(6):1010428317699111. doi: 10.1177/1010428317699111. Tumour Biol. 2017. PMID: 28618948 Free article.
Consistently, BAP1 mutation was correlated with critical clinicopathological features only in uveal melanoma and clear cell renal cell carcinoma. In uveal melanoma, BAP1 mutation and SF3B1/EIF1AX mutations were negatively correlated, and BAP1 …
Consistently, BAP1 mutation was correlated with critical clinicopathological features only in uveal melanoma and clear cell …